These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7519653)

  • 1. In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review.
    Guadagni F; Roselli M; Schlom J; Greiner JW
    Int J Biol Markers; 1994; 9(1):53-60. PubMed ID: 7519653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human tumor antigen expression by biological response modifiers (BRMs).
    Guadagni F; Roselli M; Schlom J; Greiner JW
    Ann Ist Super Sanita; 1991; 27(1):71-8. PubMed ID: 1958031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
    Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
    J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
    Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons.
    Guadagni F; Schlom J; Greiner JW
    Int J Rad Appl Instrum B; 1991; 18(4):409-12. PubMed ID: 1907601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer.
    Mahvi DM; Madsen JA; Witt PL; Sondel PM
    Cancer Immunol Immunother; 1995 May; 40(5):311-4. PubMed ID: 7600563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Mariani-Costantini R; Greiner JW; Casciani CU; Schlom J
    J Clin Oncol; 1996 Jul; 14(7):2031-42. PubMed ID: 8683233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocols.
    Ferroni P; Milenic DE; Roselli M; Carrasquillo JA; Raubitschek A; Schlom J; Colcher D
    Int J Biol Markers; 1990; 5(4):166-76. PubMed ID: 2093732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.
    Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J
    Cancer Res; 1991 Aug; 51(16):4155-63. PubMed ID: 1907881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.
    Greiner JW; Guadagni F; Hand PH; Pestka S; Noguchi P; Fisher PB; Schlom J
    Cancer Treat Res; 1990; 51():413-32. PubMed ID: 1977458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
    Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
    Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
    Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
    Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review).
    Guadagni F; Roselli M; Nieroda C; Dansky-Ullmann G; Schlom J; Greiner JW
    In Vivo; 1993; 7(6B):591-9. PubMed ID: 8193280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
    Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
    J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas.
    Guadagni F; Roselli M; Amato T; Abbolito MR; Cosimelli M; Mannella E; Greiner JW; Schlom J
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):293-6. PubMed ID: 2092139
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
    Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells.
    Greiner JW; Guadagni F; Goldstein D; Smalley RV; Borden EC; Simpson JF; Molinolo A; Schlom J
    J Clin Oncol; 1992 May; 10(5):735-46. PubMed ID: 1569446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.
    Filella X; Fuster J; Molina R; Grau JJ; García-Valdecasas JC; Grande L; Estapé J; Ballesta AM
    Acta Oncol; 1994; 33(7):747-51. PubMed ID: 7993641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.